Circassia Group is a medical devices business based in the US. Circassia Group shares (CSSPF) are listed on the OTCGREY and all prices are listed in US Dollars. Its last market close was $0.75 – the same closing value as a week prior. Circassia Group employs 92 staff and has a trailing 12-month revenue of around $39 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.75 |
|---|---|
| 52-week range | $0.74 - $0.76 |
| 50-day moving average | $0.75 |
| 200-day moving average | $0.75 |
| Wall St. target price | N/A |
| PE ratio | 25 |
| Dividend yield | $0.01 (1.68%) |
| Earnings per share (TTM) | $0.03 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.75 from 2024-11-21
| 1 week (2024-11-15) | 0.75 |
|---|---|
| 1 month (2024-10-24) | 0.75 |
| 3 months (2024-08-23) | 0.75 |
| 6 months (2024-05-23) | 0.75 |
| 1 year (2023-11-22) | -2.20% |
|---|---|
| 2 years (2022-11-23) | 67.08% |
| 3 years (2021-11-23) | 67.08% |
| 5 years (2019-11-20) | N/A |
Valuing Circassia Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Circassia Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Circassia Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, Circassia Group shares trade at around 25x recent earnings.
Circassia Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $9.5 million.
The EBITDA is a measure of a Circassia Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $39 million |
|---|---|
| Operating margin TTM | 20% |
| Gross profit TTM | $22.2 million |
| Return on assets TTM | 3.96% |
| Return on equity TTM | 13.52% |
| Profit margin | 30% |
| Book value | $0.19 |
| Market Capitalization | $384.7 million |
TTM: trailing 12 months
Dividend payout ratio: 40.98% of net profits
Recently Circassia Group has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Circassia Group shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Circassia Group's case, that would currently equate to about $0.01 per share.
While Circassia Group's payout ratio might seem fairly standard, it's worth remembering that Circassia Group may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 22 May 2024 (the "ex-dividend date").
Over the last 12 months, Circassia Group's shares have ranged in value from as little as $0.74 up to $0.7567. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (OTCGREY average) beta is 1, while Circassia Group's is 0.938. This would suggest that Circassia Group's shares are less volatile than average (for this exchange).
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom. .
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.